Please login to the form below

Not currently logged in
Email:
Password:

GE’s Fraser Black joins BioCity Scotland as MD

Replaces Ian Webster at Scottish life sciences hub

Fraser Black has been appointed as managing director at BioCity Scotland – a life sciences hub based at an old MSD facility in central Scotland.

He joins from GE Life Sciences where he was global services solutions director, and takes over from Ian Webster who had been managing director at BioCity Scotland since its launch in January, 2012.

In his new role, Black will oversee the collection of new bioscience and life sciences companies, including relationship-building with both corporate partners and the local community.

“In Newhouse, we have the resources and exceptional facilities to build a world class hub of successful life science businesses in the central belt of Scotland, and I believe the potential to add real value to the economy is enormous,” said Black. “This is the goal I will work towards as we collectively build the BioCity community here.”

Black had been at GE Life Sciences 2005 having previously held VP positions with Amersham Bioscience in both bioscience services and sales and marketing. He was also president of Hoefer Pharmacia Biotech.

“He brings business development experience honed in the international life sciences arena, as well as world-class team-building skills so we are in very good hands,” said Dr Louis Nisbet, BioCity Scotland chair.

9th July 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Influencing behaviour change: Looking beyond market research
These strategies will give you the insight you need to influence behaviour change by creating a meaningful pharma customer journey....
Precision medicine and the changing role of the healthcare professional
The growth of precision medicine introduces a shift away from treating the population as a whole, to treating each patient as an individual. How does this change the role of...
How will Sustainability and Transformation Plans (STPs) change the NHS commissioning landscape?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma...

Infographics